Global Renal Denervation Systems Market Report and Forecast 2024-2032

1    Preface
    1.1    Objectives of the Study
    1.2    Key Assumptions
    1.3    Report Coverage – Key Segmentation and Scope 
    1.4    Research Methodology                  
2    Executive  Summary
3     Global Renal Denervation Systems Market Overview 
    3.1     Global Renal Denervation Systems Market Historical Value (2017-2023) 
    3.2     Global Renal Denervation Systems Market Forecast Value (2024-2032)
4     Global Renal Denervation Systems Market Landscape*
    4.1     Global Renal Denervation Systems Market: Developers Landscape
        4.1.1    Analysis by Year of Establishment
        4.1.2    Analysis by Company Size
        4.1.3    Analysis by Region
    4.2     Global Renal Denervation Systems Market: Product Landscape
        4.2.1    Analysis by Type
        4.2.2    Analysis by Product
        4.2.3    Analysis by Technology
        4.2.4    Analysis by Application
        4.2.5    Analysis by End Use
5    Global Renal Denervation Systems Market Dynamics
    5.1    Market Drivers and Constraints
    5.2    SWOT Analysis
        5.2.1    Strengths
        5.2.2    Weaknesses
        5.2.3    Opportunities
        5.2.4    Threats
    5.3    Porter’s Five Forces Model
        5.3.1    Bargaining Power of Suppliers
        5.3.2    Bargaining Power of Buyers
        5.3.3    Threat of New Entrants
        5.3.4    Threat of Substitutes
        5.3.5    Degree of Rivalry
    5.4    Key Demand Indicators 
    5.5    Key Price Indicators
    5.6    Industry Events, Initiatives, and Trends  
    5.7    Value Chain Analysis
6     Global Renal Denervation Systems Market Segmentation (2017-2032)
    6.1    Global Renal Denervation Systems Market (2017-2032) by Type
        6.1.1    Market Overview
        6.1.2    Catheter
            6.1.2.1    Single Electrode Catheter
            6.1.2.2    Multi Electrode Catheter
        6.1.3    RF Generator
        6.1.4    Nerve Modifying Agents 
    6.2    Global Renal Denervation Systems Market (2017-2032) by Product
        6.2.1    Market Overview
        6.2.2    Simplicity 
        6.2.3    Enlightn
        6.2.4    Vessix 
        6.2.5    Paradise 
        6.2.6    Iberis
        6.2.7    Others
    6.3    Global Renal Denervation Systems Market (2017-2032) by Technology
        6.3.1    Market Overview
        6.3.2    Radiofrequency 
        6.3.3    Ultrasound 
        6.3.4    Micro-Infusion 
    6.4    Global Renal Denervation Systems Market (2017 - 2032) by Application
        6.4.1    Market Overview
        6.4.2    Hypertension
        6.4.3    Cardiac Disorders
        6.4.4    Diabetes
        6.4.5    Renal Failure
        6.4.6    Others
    6.5    Global Renal Denervation Systems Market (2017-2032) by End Use
        6.5.1    Market Overview
        6.5.2    Diagnostic Centers and Hospitals 
        6.5.3    Ambulatory Care Centers
        6.5.4    Others
    6.6    Global Renal Denervation Systems Market (2017-2032) by Region
        6.6.1    Market Overview
        6.6.2    North America
        6.6.3    Europe 
        6.6.4    Asia Pacific
        6.6.5    Latin America
        6.6.6    Middle East and Africa
7    North America Renal Denervation Systems Market (2017-2032)
    7.1    North America Renal Denervation Systems Market (2017-2032) by Type
        7.1.1    Market Overview
        7.1.2    Catheters
            7.1.2.1    Single Electrode Catheter
            7.1.2.2    Multi Electrode Catheter
        7.1.3    RF Generator
        7.1.4    Nerve Modifying Agents
    7.2    North America Renal Denervation Systems Market (2017-2032) by Product
        7.2.1    Market Overview
        7.2.2    Simplicity 
        7.2.3    Enlightn
        7.2.4    Vessix 
        7.2.5    Paradise 
        7.2.6    Iberis
        7.2.7    Others
    7.3     North America Renal Denervation Systems Market (2017-2032) by Technology
        7.3.1    Market Overview
        7.3.2    Radiofrequency 
        7.3.3    Ultrasound 
        7.3.4    Micro-Infusion 
    7.4    North America Renal Denervation Systems Market (2017 - 2032) by Application
        7.4.1    Market Overview
        7.4.2    Hypertension
        7.4.3    Cardiac Disorders
        7.4.4    Diabetes
        7.4.5    Renal Failure
       7.4.6    Others
    7.5    North America Renal Denervation Systems Market (2017-2032) by Country
        7.5.1    Market Overview
        7.5.2    United States of America
        7.5.3    Canada
8    Europe Renal  Denervation Systems Market (2017-2032)
    8.1    Europe Renal Denervation Systems Market (2017-2032) by Type
        8.1.1    Market Overview
        8.1.2    Catheters
            8.1.2.1    Single Electrode Catheter
            8.1.2.2    Multi Electrode Catheter
        8.1.3    RF Generator
        8.1.4    Nerve Modifying Agents 
    8.2    Europe Renal Denervation Systems Market (2017-2032) by Product
        8.2.1    Market Overview
        8.2.2    Simplicity 
        8.2.3    Enlightn
        8.2.4    Vessix 
        8.2.5    Paradise 
        8.2.6    Iberis
        8.2.7    Others
    8.3    Europe Renal Denervation Systems Market (2017-2032) by Technology
        8.3.1    Market Overview
        8.3.2    Radiofrequency 
        8.3.3    Ultrasound 
        8.3.4    Micro-Infusion 
    8.4    Europe Renal Denervation Systems Market (2017 - 2032) by Application
        8.4.1    Market Overview
        8.4.2    Hypertension
        8.4.3    Cardiac Disorders
        8.4.4    Diabetes
        8.4.5    Renal Failure
        8.4.6    Others
    8.5    Europe Renal Denervation Systems Market (2017-2032) by Country
        8.5.1    Market Overview
        8.5.2    United Kingdom
        8.5.3    Germany
        8.5.4    France
        8.5.5    Italy
        8.5.6    Others
9    Asia Pacific Renal Denervation Systems Market (2017-2032)
    9.1    Asia Pacific Renal Denervation Systems Market (2017-2032) by Type
        9.1.1    Market Overview
        9.1.2    Catheters
            9.1.2.1    Single Electrode Catheter
            9.1.2.2    Multi Electrode Catheter
        9.1.3    RF Generator
        9.1.4    Nerve Modifying Agents
    9.2    Asia Pacific Renal Denervation Systems Market (2017-2032) by Product
        9.2.1    Market Overview
        9.2.2    Simplicity 
        9.2.3    Enlightn
        9.2.4    Vessix 
        9.2.5    Paradise 
        9.2.6    Iberis
        9.2.7    Others
    9.3    Asia Pacific Renal Denervation Systems Market (2017-2032) by Technology
        9.3.1    Market Overview
        9.3.2    Radiofrequency 
        9.3.3    Ultrasound 
        9.3.4    Micro-Infusion 
    9.4    Asia Pacific Renal Denervation Systems Market (2017 - 2032) by Application
        9.4.1    Market Overview
        9.4.2    Hypertension
        9.4.3    Cardiac Disorders
        9.4.4    Diabetes
        9.4.5    Renal Failure
        9.4.6    Others
    9.5    Asia Pacific Renal Denervation Systems Market (2017-2032) by Country
        9.5.1    Market Overview
        9.5.2    China
        9.5.3    Japan
        9.5.4    India
        9.5.5    ASEAN
        9.5.6    Australia
        9.5.7    Others
10    Latin America  Renal Denervation Systems Market (2017-2032)
    10.1    Latin America Renal Denervation Systems Market (2017-2032) by Type
        10.1.1    Market Overview
        10.1.2    Catheters
            10.1.2.1    Single Electrode Catheter
            10.1.2.2    Multi Electrode Catheter
        10.1.3    RF Generator
        10.1.4    Nerve Modifying Agents
    10.2    Latin America Renal Denervation Systems Market (2017-2032) by Product
        10.2.1    Market Overview
        10.2.2    Simplicity 
        10.2.3    Enlightn
        10.2.4    Vessix 
        10.2.5    Paradise 
        10.2.6    Iberis
        10.2.7    Others
    10.3    Latin America Renal Denervation Systems Market (2017-2032) by Technology
        10.3.1    Market Overview
        10.3.2    Radiofrequency 
        10.3.3    Ultrasound 
        10.3.4    Micro-Infusion 
    10.4    Latin America Renal Denervation Systems Market (2017 - 2032) by Application
        10.4.1    Market Overview
        10.4.2    Hypertension
        10.4.3    Cardiac Disorders
        10.4.4    Diabetes
        10.4.5    Renal Failure
        10.4.6    Others
    10.5    Latin America Renal Denervation Systems Market (2017-2032) by Country
        10.5.1    Market Overview
        10.5.2    Brazil
        10.5.3    Argentina
        10.5.4    Mexico
        10.5.5    Others
11    Middle East and Africa Renal Denervation Systems Market (2017-2032)
    11.1    Middle East and Africa Renal Denervation Systems Market (2017-2032) by Type
        11.1.1    Market Overview
        11.1.2    Catheters
            11.1.2.1    Single Electrode Catheter
            11.1.2.2    Multi Electrode Catheter
        11.1.3    RF Generator
        11.1.4    Nerve Modifying Agents  
    11.2    Middle East and Africa Renal Denervation Systems Market (2017-2032) by Product
        11.2.1    Market Overview
        11.2.2    Simplicity 
        11.2.3    Enlightn
        11.2.4    Vessix 
        11.2.5    Paradise 
        11.2.6    Iberis
        11.2.7    Others
    11.3    Middle East and Africa Renal Denervation Systems Market (2017-2032) by Technology
        11.3.1    Market Overview
        11.3.2    Radiofrequency 
        11.3.3    Ultrasound 
        11.3.4    Micro-Infusion 
    11.4    Middle East and Africa Renal Denervation Systems Market (2017 - 2032) by Application
        11.4.1    Market Overview
        11.4.2    Hypertension
        11.4.3    Cardiac Disorders
        11.4.4    Diabetes
        11.4.5    Renal Failure
        11.4.6    Others
    11.5    Middle East and Africa Renal Denervation Systems Market (2017-2032) by Country
        11.5.1    Market Overview
        11.5.2    Saudi Arabia
        11.5.3    United Arab Emirates
        11.5.4    Nigeria
        11.5.5    South Africa
        11.5.6    Others
12    Regulatory Framework
    12.1     Regulatory Overview
        12.1.1    US FDA
        12.1.2    EU EMA
        12.1.3    INDIA CDSCO
        12.1.4    JAPAN PMDA
        12.1.5    Others
13    Patent Analysis
    13.1     Analysis by Component of Patent
    13.2     Analysis by Publication year
    13.3     Analysis by Issuing Authority
    13.4     Analysis by Patent Age
    13.5     Analysis by CPC Analysis
    13.6     Analysis by Patent Valuation 
    13.7     Analysis by Key Players
14    Grants Analysis
    14.1     Analysis by Year
    14.2     Analysis by Amount Awarded
    14.3     Analysis by Issuing Authority
    14.4     Analysis by Grant Product
    14.5     Analysis by Funding Institute
    14.6     Analysis by Departments
    14.7     Analysis by Recipient Organization 
15    Funding and Investment Analysis
    15.1     Analysis by Funding Instances
    15.2     Analysis by Component of Funding
    15.3     Analysis by Funding Amount
    15.4     Analysis by Leading Players
    15.5     Analysis by Leading Investors
    15.6     Analysis by Geography
16    Partnership and Collaborations Analysis
    16.1     Analysis by Partnership Instances
    16.2     Analysis by Component of Partnership
    16.3     Analysis by Leading Players
    16.4     Analysis by Geography
17    Supplier Landscape
    17.1    Market Share by Top 5 Companies 
    17.2    Terumo Corporation
        17.2.1    Financial Analysis
        17.2.2    Product Portfolio
        17.2.3    Demographic Reach and Achievements
        17.2.4    Mergers and Acquisitions
        17.2.5    Certifications 
    17.3    Johnson & Johnson Services, Inc. 
        17.3.1    Financial Analysis
        17.3.2    Product Portfolio
        17.3.3    Demographic Reach and Achievements
        17.3.4    Mergers and Acquisitions
        17.3.5    Certifications
    17.4    Medtronic
        17.4.1    Financial Analysis
        17.4.2    Product Portfolio
        17.4.3    Demographic Reach and Achievements
        17.4.4    Mergers and Acquisitions
        17.4.5    Certifications
    17.5    Otsuka Holdings Co., Ltd
        17.5.1    Financial Analysis
        17.5.2    Product Portfolio
        17.5.3    Demographic Reach and Achievements
        17.5.4    Mergers and Acquisitions
        17.5.5    Certifications
    17.6    Boston Scientific Corporation 
        17.6.1    Financial Analysis
        17.6.2    Product Portfolio
        17.6.3    Demographic Reach and Achievements
        17.6.4    Mergers and Acquisitions
        17.6.5    Certifications
    17.7    SympleSurgical Inc.
        17.7.1    Financial Analysis
        17.7.2    Product Portfolio
        17.7.3    Demographic Reach and Achievements
        17.7.4    Mergers and Acquisitions
        17.7.5    Certifications
    17.8    Mercator MedSystems, Inc.
        17.8.1    Financial Analysis
        17.8.2    Product Portfolio
        17.8.3    Demographic Reach and Achievements
        17.8.4    Mergers and Acquisitions
        17.8.5    Certifications
    17.9    Abbott
        17.9.1    Financial Analysis
        17.9.2    Product Portfolio
        17.9.3    Demographic Reach and Achievements
        17.9.4    Mergers and Acquisitions
        17.9.5    Certifications
18    Global Renal Denervation Systems Market – Distribution Model (Additional Insight)
    18.1     Overview 
    18.2     Potential Distributors 
    18.3     Key Parameters for Distribution Partner Assessment 
19    Key Opinion Leaders (KOL) Insights (Additional Insight)
20    Company Competitiveness Analysis (Additional Insight)
    20.1     Very Small Companies
    20.2     Small Companies
    20.3     Mid-Sized Companies
    20.4     Large Companies
    20.5     Very Large Companies
21    Payment Methods (Additional Insight)
    21.1     Government Funded
    21.2     Private Insurance
    21.3     Out-of-Pocket

*Additional insights provided are customisable as per client requirements.

* The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The EMR team strives to make this section as comprehensive as possible.